Maternal prevalence of Toxoplasma antibody based on anonymous neonatal serosurvey: a geographical analysis.
A total of 12,902 neonatal samples collected on absorbent paper for routine metabolic screening were tested anonymously for antibodies to toxoplasma. Seroprevalence varied from 19.5% in inner London, to 11.6% in suburban London, and 7.6% in non-metropolitan districts. Much of this variation appeared to be associated with the proportions of livebirths in each district to women born outside the UK. However, additional geographical variation remained and seroprevalence in UK-born women was estimated to be 12.7% in inner London, 7.5% in suburban London, and 5.5% in non-metropolitan areas. These estimates are considerably lower than any previously reported in antenatal sera in the UK. The wide geographical variation highlights a need for further research to determine the relative importance of different routes of transmission.
Ades
A E
AE
Department of Virology, Institute of Child Health, London.
Parker
S
S
Gilbert
R
R
Tookey
P A
PA
Berry
T
T
Hjelm
M
M
Wilcox
A H
AH
Cubitt
D
D
Peckham
C S
CS
D000913:Antibodies, Protozoan / Q000097:blood*; D004739:England / Q000453:epidemiology; D005260:Female; D006801:Humans; D007112:Immunity, Maternally-Acquired / Q000276:immunology*; D007223:Infant; D007231:Infant, Newborn; D015997:Neonatal Screening; D011247:Pregnancy; D015995:Prevalence; D012044:Regression Analysis; D016036:Seroepidemiologic Studies; D014123:Toxoplasmosis / Q000453:epidemiology / Q000208:ethnology / Q000276:immunology*
D000913:Antibodies, Protozoan